Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
Calgary Scientific’s ResolutionMD receives FDA clearance for diagnostic image viewing on iPhones and iPads.
The once-hot leveraged buyout market for medical device companies is slowing as the souring economy spooks investors, according to a panel of private equity fund managers at the AdvaMed conference in Washington.
Former Medtronic CEO Bill Hawkins, in an exclusive interview with MassDevice.com, tells us about the one that got away: Guidant Corp.’s stent-making operation.